GO:0003747 | translation release factor activity | 1.04e-05 | 1.02e-01 | 8.253 | 2 | 2 | 2 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.03e-04 | 1.00e+00 | 6.931 | 2 | 2 | 5 |
GO:0003723 | RNA binding | 1.29e-04 | 1.00e+00 | 2.890 | 6 | 22 | 247 |
GO:0030529 | ribonucleoprotein complex | 1.39e-04 | 1.00e+00 | 3.896 | 4 | 5 | 82 |
GO:0070937 | CRD-mediated mRNA stability complex | 1.55e-04 | 1.00e+00 | 6.668 | 2 | 2 | 6 |
GO:0044822 | poly(A) RNA binding | 1.55e-04 | 1.00e+00 | 1.933 | 10 | 45 | 799 |
GO:0010467 | gene expression | 2.51e-04 | 1.00e+00 | 2.190 | 8 | 49 | 535 |
GO:0006379 | mRNA cleavage | 3.69e-04 | 1.00e+00 | 6.083 | 2 | 2 | 9 |
GO:0008143 | poly(A) binding | 4.61e-04 | 1.00e+00 | 5.931 | 2 | 2 | 10 |
GO:0006479 | protein methylation | 5.62e-04 | 1.00e+00 | 5.794 | 2 | 2 | 11 |
GO:0000398 | mRNA splicing, via spliceosome | 7.62e-04 | 1.00e+00 | 3.253 | 4 | 15 | 128 |
GO:0031047 | gene silencing by RNA | 1.54e-03 | 1.00e+00 | 5.083 | 2 | 2 | 18 |
GO:0001649 | osteoblast differentiation | 1.77e-03 | 1.00e+00 | 3.629 | 3 | 5 | 74 |
GO:0008380 | RNA splicing | 1.95e-03 | 1.00e+00 | 2.887 | 4 | 21 | 165 |
GO:0005515 | protein binding | 2.19e-03 | 1.00e+00 | 0.703 | 22 | 198 | 4124 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.54e-03 | 1.00e+00 | 3.446 | 3 | 5 | 84 |
GO:0016592 | mediator complex | 2.98e-03 | 1.00e+00 | 4.610 | 2 | 6 | 25 |
GO:0004832 | valine-tRNA ligase activity | 3.28e-03 | 1.00e+00 | 8.253 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 3.28e-03 | 1.00e+00 | 8.253 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 3.28e-03 | 1.00e+00 | 8.253 | 1 | 1 | 1 |
GO:0008609 | alkylglycerone-phosphate synthase activity | 3.28e-03 | 1.00e+00 | 8.253 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 3.28e-03 | 1.00e+00 | 8.253 | 1 | 1 | 1 |
GO:0001554 | luteolysis | 3.28e-03 | 1.00e+00 | 8.253 | 1 | 1 | 1 |
GO:0016149 | translation release factor activity, codon specific | 3.28e-03 | 1.00e+00 | 8.253 | 1 | 1 | 1 |
GO:0031592 | centrosomal corona | 3.28e-03 | 1.00e+00 | 8.253 | 1 | 1 | 1 |
GO:0097165 | nuclear stress granule | 3.28e-03 | 1.00e+00 | 8.253 | 1 | 1 | 1 |
GO:0008079 | translation termination factor activity | 3.28e-03 | 1.00e+00 | 8.253 | 1 | 1 | 1 |
GO:0005778 | peroxisomal membrane | 4.00e-03 | 1.00e+00 | 4.395 | 2 | 3 | 29 |
GO:0017148 | negative regulation of translation | 5.16e-03 | 1.00e+00 | 4.209 | 2 | 5 | 33 |
GO:0031124 | mRNA 3'-end processing | 5.79e-03 | 1.00e+00 | 4.124 | 2 | 4 | 35 |
GO:0005654 | nucleoplasm | 6.09e-03 | 1.00e+00 | 1.479 | 8 | 68 | 876 |
GO:0003743 | translation initiation factor activity | 6.45e-03 | 1.00e+00 | 4.044 | 2 | 8 | 37 |
GO:0042036 | negative regulation of cytokine biosynthetic process | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 1 | 2 |
GO:0045309 | protein phosphorylated amino acid binding | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 1 | 2 |
GO:0008611 | ether lipid biosynthetic process | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 1 | 2 |
GO:0031111 | negative regulation of microtubule polymerization or depolymerization | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 1 | 2 |
GO:0048742 | regulation of skeletal muscle fiber development | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 1 | 2 |
GO:0030981 | cortical microtubule cytoskeleton | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 1 | 2 |
GO:0051294 | establishment of spindle orientation | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 1 | 2 |
GO:0006369 | termination of RNA polymerase II transcription | 6.80e-03 | 1.00e+00 | 4.005 | 2 | 5 | 38 |
GO:0048511 | rhythmic process | 6.80e-03 | 1.00e+00 | 4.005 | 2 | 5 | 38 |
GO:0006396 | RNA processing | 7.51e-03 | 1.00e+00 | 3.931 | 2 | 4 | 40 |
GO:0006406 | mRNA export from nucleus | 9.03e-03 | 1.00e+00 | 3.794 | 2 | 7 | 44 |
GO:0008762 | UDP-N-acetylmuramate dehydrogenase activity | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 1 | 3 |
GO:0036123 | histone H3-K9 dimethylation | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 1 | 3 |
GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 1 | 3 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 2 | 3 |
GO:0002192 | IRES-dependent translational initiation | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 2 | 3 |
GO:0003407 | neural retina development | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 2 | 4 |
GO:0097452 | GAIT complex | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 2 | 4 |
GO:0016020 | membrane | 1.30e-02 | 1.00e+00 | 1.186 | 9 | 56 | 1207 |
GO:0007000 | nucleolus organization | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 1 | 4 |
GO:0051151 | negative regulation of smooth muscle cell differentiation | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 1 | 4 |
GO:0045292 | mRNA cis splicing, via spliceosome | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 1 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 2 | 4 |
GO:0006449 | regulation of translational termination | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 1 | 4 |
GO:0036124 | histone H3-K9 trimethylation | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 2 | 4 |
GO:0006333 | chromatin assembly or disassembly | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 1 | 4 |
GO:0043515 | kinetochore binding | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 2 | 4 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.44e-02 | 1.00e+00 | 3.446 | 2 | 5 | 56 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 3 | 5 |
GO:0008610 | lipid biosynthetic process | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 5 |
GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 5 |
GO:0032790 | ribosome disassembly | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 2 | 5 |
GO:0005828 | kinetochore microtubule | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 5 |
GO:0048024 | regulation of mRNA splicing, via spliceosome | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 5 |
GO:0000127 | transcription factor TFIIIC complex | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 3 | 5 |
GO:0031023 | microtubule organizing center organization | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 5 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 3 | 5 |
GO:0004521 | endoribonuclease activity | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 5 |
GO:0010458 | exit from mitosis | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 2 | 5 |
GO:0006398 | histone mRNA 3'-end processing | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 5 |
GO:0006282 | regulation of DNA repair | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 2 | 5 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 5 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.64e-02 | 1.00e+00 | 3.347 | 2 | 5 | 60 |
GO:0071013 | catalytic step 2 spliceosome | 1.69e-02 | 1.00e+00 | 3.323 | 2 | 5 | 61 |
GO:0016071 | mRNA metabolic process | 1.78e-02 | 1.00e+00 | 2.429 | 3 | 10 | 170 |
GO:0006415 | translational termination | 1.79e-02 | 1.00e+00 | 3.276 | 2 | 2 | 63 |
GO:0005739 | mitochondrion | 1.85e-02 | 1.00e+00 | 1.474 | 6 | 32 | 659 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.90e-02 | 1.00e+00 | 3.231 | 2 | 7 | 65 |
GO:0050847 | progesterone receptor signaling pathway | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 6 |
GO:0042754 | negative regulation of circadian rhythm | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 2 | 6 |
GO:0046974 | histone methyltransferase activity (H3-K9 specific) | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 6 |
GO:0035234 | ectopic germ cell programmed cell death | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 6 |
GO:0004842 | ubiquitin-protein transferase activity | 2.03e-02 | 1.00e+00 | 2.355 | 3 | 17 | 179 |
GO:0002199 | zona pellucida receptor complex | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 4 | 7 |
GO:0007140 | male meiosis | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 1 | 7 |
GO:0008409 | 5'-3' exonuclease activity | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 2 | 7 |
GO:0000339 | RNA cap binding | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 1 | 7 |
GO:0042753 | positive regulation of circadian rhythm | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 1 | 7 |
GO:0000731 | DNA synthesis involved in DNA repair | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 2 | 7 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 2 | 7 |
GO:0005832 | chaperonin-containing T-complex | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 4 | 7 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 1 | 7 |
GO:0016070 | RNA metabolic process | 2.31e-02 | 1.00e+00 | 2.284 | 3 | 10 | 188 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.43e-02 | 1.00e+00 | 1.840 | 4 | 23 | 341 |
GO:0005845 | mRNA cap binding complex | 2.59e-02 | 1.00e+00 | 5.253 | 1 | 1 | 8 |
GO:0006450 | regulation of translational fidelity | 2.59e-02 | 1.00e+00 | 5.253 | 1 | 1 | 8 |
GO:0071949 | FAD binding | 2.59e-02 | 1.00e+00 | 5.253 | 1 | 1 | 8 |
GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.59e-02 | 1.00e+00 | 5.253 | 1 | 1 | 8 |
GO:0004535 | poly(A)-specific ribonuclease activity | 2.59e-02 | 1.00e+00 | 5.253 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 2.59e-02 | 1.00e+00 | 5.253 | 1 | 1 | 8 |
GO:0034453 | microtubule anchoring | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 1 | 9 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 1 | 9 |
GO:0061136 | regulation of proteasomal protein catabolic process | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 1 | 9 |
GO:0071354 | cellular response to interleukin-6 | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 1 | 9 |
GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 2 | 9 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 3 | 9 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 1 | 9 |
GO:0033598 | mammary gland epithelial cell proliferation | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 1 | 9 |
GO:0010225 | response to UV-C | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 2 | 9 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 2 | 9 |
GO:0042974 | retinoic acid receptor binding | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 1 | 10 |
GO:0001578 | microtubule bundle formation | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 2 | 10 |
GO:0030014 | CCR4-NOT complex | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 1 | 10 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 1 | 10 |
GO:0051010 | microtubule plus-end binding | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 2 | 11 |
GO:0007026 | negative regulation of microtubule depolymerization | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 2 | 11 |
GO:0008334 | histone mRNA metabolic process | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 1 | 11 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 4 | 11 |
GO:0007020 | microtubule nucleation | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 1 | 11 |
GO:2000036 | regulation of stem cell maintenance | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 1 | 11 |
GO:0045807 | positive regulation of endocytosis | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 1 | 11 |
GO:0000209 | protein polyubiquitination | 3.63e-02 | 1.00e+00 | 2.730 | 2 | 6 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 3.63e-02 | 1.00e+00 | 2.730 | 2 | 6 | 92 |
GO:0016409 | palmitoyltransferase activity | 3.86e-02 | 1.00e+00 | 4.668 | 1 | 1 | 12 |
GO:0000086 | G2/M transition of mitotic cell cycle | 3.99e-02 | 1.00e+00 | 2.653 | 2 | 7 | 97 |
GO:0017091 | AU-rich element binding | 4.18e-02 | 1.00e+00 | 4.553 | 1 | 2 | 13 |
GO:0005680 | anaphase-promoting complex | 4.18e-02 | 1.00e+00 | 4.553 | 1 | 2 | 13 |
GO:0001731 | formation of translation preinitiation complex | 4.49e-02 | 1.00e+00 | 4.446 | 1 | 3 | 14 |
GO:0016575 | histone deacetylation | 4.49e-02 | 1.00e+00 | 4.446 | 1 | 2 | 14 |
GO:0008135 | translation factor activity, nucleic acid binding | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 4 | 15 |
GO:0097194 | execution phase of apoptosis | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 1 | 15 |
GO:0018345 | protein palmitoylation | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 1 | 15 |
GO:0045879 | negative regulation of smoothened signaling pathway | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 4 | 15 |
GO:0030864 | cortical actin cytoskeleton | 5.12e-02 | 1.00e+00 | 4.253 | 1 | 1 | 16 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 5.12e-02 | 1.00e+00 | 4.253 | 1 | 1 | 16 |
GO:0016485 | protein processing | 5.12e-02 | 1.00e+00 | 4.253 | 1 | 1 | 16 |
GO:0031648 | protein destabilization | 5.12e-02 | 1.00e+00 | 4.253 | 1 | 2 | 16 |
GO:0003887 | DNA-directed DNA polymerase activity | 5.12e-02 | 1.00e+00 | 4.253 | 1 | 2 | 16 |
GO:0005782 | peroxisomal matrix | 5.12e-02 | 1.00e+00 | 4.253 | 1 | 1 | 16 |
GO:0005829 | cytosol | 5.41e-02 | 1.00e+00 | 0.772 | 10 | 88 | 1787 |
GO:0001829 | trophectodermal cell differentiation | 5.43e-02 | 1.00e+00 | 4.166 | 1 | 2 | 17 |
GO:0045862 | positive regulation of proteolysis | 5.43e-02 | 1.00e+00 | 4.166 | 1 | 3 | 17 |
GO:0019706 | protein-cysteine S-palmitoyltransferase activity | 5.43e-02 | 1.00e+00 | 4.166 | 1 | 1 | 17 |
GO:0043022 | ribosome binding | 5.43e-02 | 1.00e+00 | 4.166 | 1 | 2 | 17 |
GO:0006378 | mRNA polyadenylation | 5.74e-02 | 1.00e+00 | 4.083 | 1 | 3 | 18 |
GO:2001235 | positive regulation of apoptotic signaling pathway | 6.05e-02 | 1.00e+00 | 4.005 | 1 | 2 | 19 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 6.05e-02 | 1.00e+00 | 4.005 | 1 | 1 | 19 |
GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic | 6.05e-02 | 1.00e+00 | 4.005 | 1 | 1 | 19 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 6.05e-02 | 1.00e+00 | 4.005 | 1 | 1 | 19 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 6.05e-02 | 1.00e+00 | 4.005 | 1 | 1 | 19 |
GO:0006913 | nucleocytoplasmic transport | 6.36e-02 | 1.00e+00 | 3.931 | 1 | 2 | 20 |
GO:0070979 | protein K11-linked ubiquitination | 6.36e-02 | 1.00e+00 | 3.931 | 1 | 3 | 20 |
GO:0019005 | SCF ubiquitin ligase complex | 6.36e-02 | 1.00e+00 | 3.931 | 1 | 1 | 20 |
GO:0071346 | cellular response to interferon-gamma | 6.36e-02 | 1.00e+00 | 3.931 | 1 | 2 | 20 |
GO:0005720 | nuclear heterochromatin | 6.36e-02 | 1.00e+00 | 3.931 | 1 | 3 | 20 |
GO:0034660 | ncRNA metabolic process | 6.36e-02 | 1.00e+00 | 3.931 | 1 | 1 | 20 |
GO:0007163 | establishment or maintenance of cell polarity | 6.36e-02 | 1.00e+00 | 3.931 | 1 | 1 | 20 |
GO:0071897 | DNA biosynthetic process | 6.36e-02 | 1.00e+00 | 3.931 | 1 | 2 | 20 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 6.67e-02 | 1.00e+00 | 3.861 | 1 | 2 | 21 |
GO:0051084 | 'de novo' posttranslational protein folding | 6.97e-02 | 1.00e+00 | 3.794 | 1 | 4 | 22 |
GO:0030331 | estrogen receptor binding | 6.97e-02 | 1.00e+00 | 3.794 | 1 | 2 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 6.97e-02 | 1.00e+00 | 3.794 | 1 | 1 | 22 |
GO:0005881 | cytoplasmic microtubule | 7.58e-02 | 1.00e+00 | 3.668 | 1 | 3 | 24 |
GO:0006370 | 7-methylguanosine mRNA capping | 7.58e-02 | 1.00e+00 | 3.668 | 1 | 5 | 24 |
GO:0007162 | negative regulation of cell adhesion | 7.58e-02 | 1.00e+00 | 3.668 | 1 | 2 | 24 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 7.58e-02 | 1.00e+00 | 3.668 | 1 | 4 | 24 |
GO:0005876 | spindle microtubule | 7.58e-02 | 1.00e+00 | 3.668 | 1 | 4 | 24 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 7.89e-02 | 1.00e+00 | 3.610 | 1 | 3 | 25 |
GO:0007094 | mitotic spindle assembly checkpoint | 7.89e-02 | 1.00e+00 | 3.610 | 1 | 4 | 25 |
GO:0009267 | cellular response to starvation | 8.19e-02 | 1.00e+00 | 3.553 | 1 | 1 | 26 |
GO:0010494 | cytoplasmic stress granule | 8.19e-02 | 1.00e+00 | 3.553 | 1 | 4 | 26 |
GO:0016874 | ligase activity | 8.23e-02 | 1.00e+00 | 2.064 | 2 | 11 | 146 |
GO:0000278 | mitotic cell cycle | 8.24e-02 | 1.00e+00 | 1.544 | 3 | 28 | 314 |
GO:0045892 | negative regulation of transcription, DNA-templated | 8.42e-02 | 1.00e+00 | 1.530 | 3 | 17 | 317 |
GO:0006418 | tRNA aminoacylation for protein translation | 9.09e-02 | 1.00e+00 | 3.395 | 1 | 4 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 9.09e-02 | 1.00e+00 | 3.395 | 1 | 6 | 29 |
GO:0042752 | regulation of circadian rhythm | 9.09e-02 | 1.00e+00 | 3.395 | 1 | 5 | 29 |
GO:0006446 | regulation of translational initiation | 9.09e-02 | 1.00e+00 | 3.395 | 1 | 2 | 29 |
GO:0097192 | extrinsic apoptotic signaling pathway in absence of ligand | 9.69e-02 | 1.00e+00 | 3.299 | 1 | 1 | 31 |
GO:0015030 | Cajal body | 9.99e-02 | 1.00e+00 | 3.253 | 1 | 3 | 32 |
GO:0007067 | mitotic nuclear division | 1.01e-01 | 1.00e+00 | 1.887 | 2 | 9 | 165 |
GO:0071407 | cellular response to organic cyclic compound | 1.06e-01 | 1.00e+00 | 3.166 | 1 | 2 | 34 |
GO:0044267 | cellular protein metabolic process | 1.07e-01 | 1.00e+00 | 1.379 | 3 | 14 | 352 |
GO:0044297 | cell body | 1.09e-01 | 1.00e+00 | 3.124 | 1 | 5 | 35 |
GO:0050434 | positive regulation of viral transcription | 1.09e-01 | 1.00e+00 | 3.124 | 1 | 5 | 35 |
GO:0000226 | microtubule cytoskeleton organization | 1.12e-01 | 1.00e+00 | 3.083 | 1 | 1 | 36 |
GO:0000166 | nucleotide binding | 1.13e-01 | 1.00e+00 | 1.794 | 2 | 13 | 176 |
GO:0004197 | cysteine-type endopeptidase activity | 1.15e-01 | 1.00e+00 | 3.044 | 1 | 1 | 37 |
GO:0006412 | translation | 1.15e-01 | 1.00e+00 | 1.778 | 2 | 12 | 178 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.17e-01 | 1.00e+00 | 3.005 | 1 | 4 | 38 |
GO:0019827 | stem cell maintenance | 1.20e-01 | 1.00e+00 | 2.968 | 1 | 4 | 39 |
GO:0006417 | regulation of translation | 1.20e-01 | 1.00e+00 | 2.968 | 1 | 2 | 39 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.23e-01 | 1.00e+00 | 2.931 | 1 | 4 | 40 |
GO:0016567 | protein ubiquitination | 1.26e-01 | 1.00e+00 | 1.699 | 2 | 14 | 188 |
GO:0000775 | chromosome, centromeric region | 1.26e-01 | 1.00e+00 | 2.896 | 1 | 6 | 41 |
GO:0043525 | positive regulation of neuron apoptotic process | 1.26e-01 | 1.00e+00 | 2.896 | 1 | 1 | 41 |
GO:0003684 | damaged DNA binding | 1.26e-01 | 1.00e+00 | 2.896 | 1 | 1 | 41 |
GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | 1.29e-01 | 1.00e+00 | 2.861 | 1 | 2 | 42 |
GO:0000932 | cytoplasmic mRNA processing body | 1.32e-01 | 1.00e+00 | 2.827 | 1 | 3 | 43 |
GO:0005525 | GTP binding | 1.36e-01 | 1.00e+00 | 1.631 | 2 | 12 | 197 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 1.38e-01 | 1.00e+00 | 2.762 | 1 | 2 | 45 |
GO:0008013 | beta-catenin binding | 1.38e-01 | 1.00e+00 | 2.762 | 1 | 3 | 45 |
GO:0019903 | protein phosphatase binding | 1.43e-01 | 1.00e+00 | 2.699 | 1 | 2 | 47 |
GO:0000151 | ubiquitin ligase complex | 1.46e-01 | 1.00e+00 | 2.668 | 1 | 4 | 48 |
GO:0051301 | cell division | 1.49e-01 | 1.00e+00 | 2.639 | 1 | 2 | 49 |
GO:0019899 | enzyme binding | 1.50e-01 | 1.00e+00 | 1.539 | 2 | 7 | 210 |
GO:0005777 | peroxisome | 1.52e-01 | 1.00e+00 | 2.610 | 1 | 2 | 50 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.57e-01 | 1.00e+00 | 2.553 | 1 | 3 | 52 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.57e-01 | 1.00e+00 | 2.553 | 1 | 8 | 52 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 1.60e-01 | 1.00e+00 | 2.525 | 1 | 3 | 53 |
GO:0016032 | viral process | 1.64e-01 | 1.00e+00 | 1.097 | 3 | 30 | 428 |
GO:0071260 | cellular response to mechanical stimulus | 1.66e-01 | 1.00e+00 | 2.472 | 1 | 2 | 55 |
GO:0000776 | kinetochore | 1.66e-01 | 1.00e+00 | 2.472 | 1 | 8 | 55 |
GO:0006338 | chromatin remodeling | 1.66e-01 | 1.00e+00 | 2.472 | 1 | 7 | 55 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 1.68e-01 | 1.00e+00 | 2.446 | 1 | 1 | 56 |
GO:0003697 | single-stranded DNA binding | 1.71e-01 | 1.00e+00 | 2.421 | 1 | 4 | 57 |
GO:0008584 | male gonad development | 1.71e-01 | 1.00e+00 | 2.421 | 1 | 1 | 57 |
GO:0000777 | condensed chromosome kinetochore | 1.71e-01 | 1.00e+00 | 2.421 | 1 | 6 | 57 |
GO:0042826 | histone deacetylase binding | 1.74e-01 | 1.00e+00 | 2.395 | 1 | 5 | 58 |
GO:0000785 | chromatin | 1.77e-01 | 1.00e+00 | 2.371 | 1 | 6 | 59 |
GO:0006470 | protein dephosphorylation | 1.82e-01 | 1.00e+00 | 2.323 | 1 | 2 | 61 |
GO:0006464 | cellular protein modification process | 1.82e-01 | 1.00e+00 | 2.323 | 1 | 4 | 61 |
GO:0016337 | single organismal cell-cell adhesion | 1.85e-01 | 1.00e+00 | 2.299 | 1 | 3 | 62 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.86e-01 | 1.00e+00 | 1.005 | 3 | 29 | 456 |
GO:0030018 | Z disc | 1.90e-01 | 1.00e+00 | 2.253 | 1 | 3 | 64 |
GO:0006364 | rRNA processing | 1.98e-01 | 1.00e+00 | 2.187 | 1 | 2 | 67 |
GO:0051082 | unfolded protein binding | 2.06e-01 | 1.00e+00 | 2.124 | 1 | 5 | 70 |
GO:0030308 | negative regulation of cell growth | 2.06e-01 | 1.00e+00 | 2.124 | 1 | 3 | 70 |
GO:0051726 | regulation of cell cycle | 2.14e-01 | 1.00e+00 | 2.064 | 1 | 3 | 73 |
GO:0071456 | cellular response to hypoxia | 2.22e-01 | 1.00e+00 | 2.005 | 1 | 2 | 76 |
GO:0005938 | cell cortex | 2.24e-01 | 1.00e+00 | 1.987 | 1 | 6 | 77 |
GO:0097190 | apoptotic signaling pathway | 2.39e-01 | 1.00e+00 | 1.878 | 1 | 1 | 83 |
GO:0016055 | Wnt signaling pathway | 2.49e-01 | 1.00e+00 | 1.810 | 1 | 6 | 87 |
GO:0044255 | cellular lipid metabolic process | 2.54e-01 | 1.00e+00 | 1.778 | 1 | 2 | 89 |
GO:0046983 | protein dimerization activity | 2.67e-01 | 1.00e+00 | 1.699 | 1 | 2 | 94 |
GO:0006260 | DNA replication | 2.67e-01 | 1.00e+00 | 1.699 | 1 | 9 | 94 |
GO:0008017 | microtubule binding | 2.74e-01 | 1.00e+00 | 1.653 | 1 | 9 | 97 |
GO:0006351 | transcription, DNA-templated | 2.74e-01 | 1.00e+00 | 0.504 | 5 | 47 | 1076 |
GO:0006457 | protein folding | 2.74e-01 | 1.00e+00 | 1.653 | 1 | 5 | 97 |
GO:0007568 | aging | 2.74e-01 | 1.00e+00 | 1.653 | 1 | 3 | 97 |
GO:0006413 | translational initiation | 2.79e-01 | 1.00e+00 | 1.624 | 1 | 6 | 99 |
GO:0030335 | positive regulation of cell migration | 2.83e-01 | 1.00e+00 | 1.595 | 1 | 2 | 101 |
GO:0010628 | positive regulation of gene expression | 2.95e-01 | 1.00e+00 | 1.525 | 1 | 2 | 106 |
GO:0042981 | regulation of apoptotic process | 3.09e-01 | 1.00e+00 | 1.446 | 1 | 4 | 112 |
GO:0007049 | cell cycle | 3.16e-01 | 1.00e+00 | 1.408 | 1 | 8 | 115 |
GO:0042802 | identical protein binding | 3.24e-01 | 1.00e+00 | 0.786 | 2 | 15 | 354 |
GO:0003924 | GTPase activity | 3.25e-01 | 1.00e+00 | 1.359 | 1 | 7 | 119 |
GO:0007420 | brain development | 3.25e-01 | 1.00e+00 | 1.359 | 1 | 3 | 119 |
GO:0005524 | ATP binding | 3.34e-01 | 1.00e+00 | 0.453 | 4 | 37 | 892 |
GO:0000082 | G1/S transition of mitotic cell cycle | 3.38e-01 | 1.00e+00 | 1.288 | 1 | 4 | 125 |
GO:0006184 | GTP catabolic process | 3.49e-01 | 1.00e+00 | 1.231 | 1 | 7 | 130 |
GO:0019904 | protein domain specific binding | 3.49e-01 | 1.00e+00 | 1.231 | 1 | 4 | 130 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.52e-01 | 1.00e+00 | 0.695 | 2 | 21 | 377 |
GO:0005730 | nucleolus | 3.68e-01 | 1.00e+00 | 0.326 | 5 | 74 | 1217 |
GO:0044212 | transcription regulatory region DNA binding | 3.77e-01 | 1.00e+00 | 1.094 | 1 | 13 | 143 |
GO:0005622 | intracellular | 3.81e-01 | 1.00e+00 | 1.073 | 1 | 2 | 145 |
GO:0006915 | apoptotic process | 3.92e-01 | 1.00e+00 | 0.570 | 2 | 15 | 411 |
GO:0001701 | in utero embryonic development | 3.99e-01 | 1.00e+00 | 0.987 | 1 | 7 | 154 |
GO:0005874 | microtubule | 4.17e-01 | 1.00e+00 | 0.905 | 1 | 10 | 163 |
GO:0006355 | regulation of transcription, DNA-templated | 4.19e-01 | 1.00e+00 | 0.357 | 3 | 31 | 715 |
GO:0008270 | zinc ion binding | 4.30e-01 | 1.00e+00 | 0.333 | 3 | 39 | 727 |
GO:0003779 | actin binding | 4.47e-01 | 1.00e+00 | 0.770 | 1 | 3 | 179 |
GO:0005575 | cellular_component | 4.62e-01 | 1.00e+00 | 0.707 | 1 | 4 | 187 |
GO:0005743 | mitochondrial inner membrane | 4.80e-01 | 1.00e+00 | 0.631 | 1 | 9 | 197 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 4.83e-01 | 1.00e+00 | 0.617 | 1 | 8 | 199 |
GO:0043065 | positive regulation of apoptotic process | 4.88e-01 | 1.00e+00 | 0.595 | 1 | 7 | 202 |
GO:0006281 | DNA repair | 4.90e-01 | 1.00e+00 | 0.588 | 1 | 24 | 203 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 4.90e-01 | 1.00e+00 | 0.588 | 1 | 14 | 203 |
GO:0030154 | cell differentiation | 4.92e-01 | 1.00e+00 | 0.581 | 1 | 5 | 204 |
GO:0005634 | nucleus | 5.12e-01 | 1.00e+00 | 0.048 | 11 | 158 | 3246 |
GO:0005813 | centrosome | 5.13e-01 | 1.00e+00 | 0.492 | 1 | 10 | 217 |
GO:0043231 | intracellular membrane-bounded organelle | 5.15e-01 | 1.00e+00 | 0.485 | 1 | 8 | 218 |
GO:0007411 | axon guidance | 5.45e-01 | 1.00e+00 | 0.365 | 1 | 8 | 237 |
GO:0003682 | chromatin binding | 5.67e-01 | 1.00e+00 | 0.276 | 1 | 15 | 252 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 5.77e-01 | 1.00e+00 | 0.069 | 2 | 22 | 582 |
GO:0006508 | proteolysis | 5.85e-01 | 1.00e+00 | 0.209 | 1 | 11 | 264 |
GO:0043565 | sequence-specific DNA binding | 6.00e-01 | 1.00e+00 | 0.150 | 1 | 8 | 275 |
GO:0046872 | metal ion binding | 6.02e-01 | 1.00e+00 | -0.029 | 3 | 24 | 934 |
GO:0008285 | negative regulation of cell proliferation | 6.02e-01 | 1.00e+00 | 0.140 | 1 | 11 | 277 |
GO:0007165 | signal transduction | 6.10e-01 | 1.00e+00 | -0.018 | 2 | 24 | 618 |
GO:0009986 | cell surface | 6.21e-01 | 1.00e+00 | 0.069 | 1 | 5 | 291 |
GO:0003674 | molecular_function | 6.28e-01 | 1.00e+00 | 0.039 | 1 | 4 | 297 |
GO:0055114 | oxidation-reduction process | 6.42e-01 | 1.00e+00 | -0.013 | 1 | 9 | 308 |
GO:0005783 | endoplasmic reticulum | 7.21e-01 | 1.00e+00 | -0.320 | 1 | 12 | 381 |
GO:0005794 | Golgi apparatus | 7.51e-01 | 1.00e+00 | -0.444 | 1 | 6 | 415 |
GO:0005737 | cytoplasm | 8.00e-01 | 1.00e+00 | -0.302 | 7 | 127 | 2633 |
GO:0003677 | DNA binding | 8.31e-01 | 1.00e+00 | -0.634 | 2 | 52 | 947 |
GO:0005887 | integral component of plasma membrane | 8.57e-01 | 1.00e+00 | -0.914 | 1 | 8 | 575 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 8.88e-01 | 1.00e+00 | -1.078 | 1 | 29 | 644 |
GO:0005615 | extracellular space | 8.90e-01 | 1.00e+00 | -1.093 | 1 | 15 | 651 |
GO:0070062 | extracellular vesicular exosome | 9.23e-01 | 1.00e+00 | -0.842 | 3 | 51 | 1641 |
GO:0044281 | small molecule metabolic process | 9.45e-01 | 1.00e+00 | -1.468 | 1 | 35 | 844 |
GO:0005886 | plasma membrane | 9.87e-01 | 1.00e+00 | -1.547 | 2 | 46 | 1784 |
GO:0016021 | integral component of membrane | 9.96e-01 | 1.00e+00 | -2.322 | 1 | 19 | 1526 |